Form D · Pharmaceuticals
Tonix Pharmaceuticals Holding Corp.
New York, NY · CIK 0001430306
Offering snapshot reported Oct 10, 2017 · SEC filing
- Reported sold
- $315K Offering amount: $15.3M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 28, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 10, 2017 | Initial | $314,798 | No comparison | 1 | SEC filing |
| Dec 26, 2012 | Amendment | $3,325,000 | $1,000,000vs Dec 12, 2012 | 26 | SEC filing |
| Dec 12, 2012 | Initial | $2,325,000 | No comparison | 25 | SEC filing |
| Nov 20, 2012 | Initial | $710,000 | No comparison | 10 | SEC filing |
| Jan 31, 2012 | Initial | $4,302,950 | No comparison | 81 | SEC filing |
| Oct 20, 2011 | Initial | $1,625,000 | No comparison | 16 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-296302
73,039 shares issued to Lincoln Park on 10/28/2017 as initial consideration for put right granted to the Company under the equity line agreement. Such shares are valued solely for purposes of this Form D at $4.31 (the closing stock price on 10/27/2017).
Source: Form D, filed Oct 10, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Margaret Smith Bell | Director |
| Bruce Daugherty | Executive |
| Stuart Davidson | Director |
| Leland Gershell | Executive |
| Patrick Grace | Director |
| Susan Kerridge | Executive |
| Donald W. Landry | Director |
| Seth Lederman | Director, Executive |
| Ernest Mario | Director |
| Charles Mather | Director |
| Charles E. Mather Iv | Director |
| David Moss | Director |
| John Rhodes | Director |
| Rhonda Rosen | Executive |
| Bradley Saenger | Executive |
| Samuel Saks | Director |
| Benjamin Selzer | Executive |
| Gregory Sullivan | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
509 Madison Avenue Suite 306
New York, NY, 10022
New York, NY, 10022